Free Trial

biote Q2 2024 Earnings Report

biote logo
$3.63 +0.30 (+9.01%)
As of 04:00 PM Eastern

biote EPS Results

Actual EPS
$0.14
Consensus EPS
$0.09
Beat/Miss
Beat by +$0.05
One Year Ago EPS
N/A

biote Revenue Results

Actual Revenue
$49.17 million
Expected Revenue
$50.40 million
Beat/Miss
Missed by -$1.23 million
YoY Revenue Growth
N/A

biote Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

biote Earnings Headlines

Marc Beer Buys Handful Of Shares In biote
biote (BTMD) Gets a Buy from Craig-Hallum
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Biote price target lowered to $6 from $8 at TD Cowen
biote (BTMD) Receives a Buy from Truist Financial
See More biote Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like biote? Sign up for Earnings360's daily newsletter to receive timely earnings updates on biote and other key companies, straight to your email.

About biote

biote (NASDAQ:BTMD) operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

View biote Profile

More Earnings Resources from MarketBeat